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Abstract 
 
Chronic low level exposure to organophosphate (OPs) pesticides in adulthood has been linked to adverse neurobehavioural 
deficits and psychological disorder symptoms, although this remains a contentious issue.  The OP-induced biological changes 
that could underlie these effects are unclear. We assessed gene expression changes following chronic low level exposure to 
diazinon, a pesticide with a high dietary exposure risk.  Adult male rats were orally exposed to diazinon (0, 1, 2 mg/kg, 5 days 
a week for 12 weeks).  After 4 weeks, there was a difference in anxiety-like behaviour in the marble burying test between 
diazinon and vehicle exposed rats; this difference persisted for 8 weeks.  Chronic diazinon exposure did not significantly 
inhibit acetylcholinesterase activity, the primary mechanism of action of high level OPs. Affymetrix GeneChip® HT RG-230 
PM Arrays were used for gene profiling followed by Ingenuity Pathway analysis.  In the hippocampus, the most significant 
gene expression changes caused by OP exposure were associated with Psychological Disorders, and Cell-To-Cell Signalling 
and Interaction functions. Genes encoding the AMPA3 glutamate receptor, glutaminase, dopamine transporter and tyrosine 
hydroxylase were up-regulated, whereas the gene encoding the GABAB1 receptor was down-regulated.  In the dorsal raphe 
nucleus, genes associated with development and the Psychological Disorders function were significantly affected, including 
the up-regulation of the gene encoding the α1b-adrenoceptor, the major driver of serotoninergic (5-HT) neuronal activity. 
These data indicate that chronic exposure to diazinon in adulthood, below the threshold to inhibit acetylcholinesterase, 
stimulates glutamatergic, dopaminergic and serotonergic synaptic transmission which may underlie adverse neurological 
outcomes.   
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1. Introduction 
Organophosphate (OPs) chemicals are commonly used worldwide to kill or repel pests in agriculture and horticulture 
and are also used in the home. Acute exposure results in hypercholinergic toxicity characterised by miosis, lacrimation, 
salivation, diarrhoea, bradycardia, bronchospasm, confusion, nausea and dizziness (Morris et al., 2014).  The effects can 
develop further to paralysis, seizures, coma and cardiorespiratory failure. One to three days after the acute cholinergic crisis, 
an intermediate syndrome occurs, characterised by limb weakness and respiratory muscle paralysis. 
Whilst acute OP poisoning is well characterised, the health effects of low level OP exposure remain contentious. 
Some studies report that low level OP exposure is associated with neurobehavioural impairments; workers exposed to 
quinalphos during manufacturing processes demonstrated a reduction in memory, learning and vigilance (Srivastava et al., 
2000) and sheep farmers exposed to OPs for an average of 23 years, showed reduced performance in mental flexibility, visual 
working and auditory memory (Mackenzie Ross et al., 2010).  Other studies have reported no association between chronic low 
level OP use and neurobehavioural performance (Daniell et al., 1992; Rodnitzky et al., 1975; Steenland et al., 2000) although 
a recent meta-analysis on 22 occupational OP exposure studies found that memory and attention scores were consistently lower 
in chronically exposed workers than in unexposed workers (Meyer-Baron et al., 2015).  Chronic low level OP exposure has 
also been associated with  psychological disorder symptoms; OP exposed greenhouse workers (Bazylewicz-Walczak et al., 
1999), tobacco workers (Salvi et al., 2003) and termiticide applicators (Steenland et al., 2000) showed elevated levels of 
anxiety and depression. In a 1995 study, sheep farmers had 50% greater susceptibility to psychiatric disorders than controls 
(Stephens et al., 1995). This was supported by a further study in which over 40% of the exposed sheep farmers had clinically 
significant levels of anxiety and depression compared to fewer than 23% of controls (Mackenzie Ross et al., 2010). In contrast, 
depression was elevated but not significantly in UK farmers chronically exposed to low levels of pesticides in a different study 
(Povey et al., 2014).  Fiedler et al. (Fiedler et al., 1997) also reported no significant association between levels of anxiety and 
depression and low level pesticide use in fruit tree workers. Inconsistencies between studies means there is uncertainty about 
attributing adverse neurological outcomes to low level OP exposure.   The lack of a plausible mechanism of action adds to the 
uncertainty.    
The mechanism of action of OPs in acute poisoning is well established.  The enzyme acetylcholinesterase (AChE) 
is inhibited, leading to acetylcholine accumulation in the central and autonomic nervous systems, and at neuromuscular 
junctions.  Activation and then subsequent desensitisation of muscarinic and nicotinic cholinergic receptors by the excess 
 acetylcholine leads to the characteristic hypercholinergic symptoms. In contrast to acute OP poisoning, the diversity of adverse 
neurological outcomes associated with low level OP exposure suggests that more than one specific neurotransmitter system is 
disrupted.   
Investigations to understand the changes in the brain following low level exposure have mainly focused on 
developmental exposure rather than adulthood exposure.  Developmental OP exposure alters the expression of genes involved 
in neural cell development, signalling and transcription control, cytotoxicity and apoptosis, potentially causing neural cell loss   
(Mankame et al., 2006; Slotkin and Seidler, 2007a; Slotkin and Seidler, 2010; Slotkin and Seidler, 2012).  It also alters the 
expression of genes related to synthesis, storage and degradation (tph, slc18a2, β-hydroxylase, slc6a2, chga and chgb) and 
neurotransmission (htr2a, htr6, htr3b, htr5a, drd4) of the monoamine neurotransmitters 5-HT and dopamine (Aldridge et al., 
2003; Slotkin and Seidler, 2007a; Slotkin and Seidler, 2007b).  This is perhaps the result of OPs inducing cells to differentiate 
into monoaminergic neurones (Jameson et al., 2006).  Neural cell loss and changes in monoaminergic transmission probably 
underlie the memory deficits, anhedonia and anxiety-like behaviour observed in animals following neonatal exposure to the 
OPs chlorpyrifos (Aldridge et al., 2005; Levin et al., 2001) and diazinon (Roegge et al., 2008; Timofeeva et al., 2008).   Whilst 
these adverse outcomes are similar to those associated with chronic low level OP exposure in adults, the mechanisms 
underlying such outcomes may not necessarily be similar. During the prenatal and neonatal period, the developing brain is 
vulnerable to chemical exposure causing a generalised disruption of cellular replication, migration and differentiation.  As 
there is relatively little neural proliferation in the mature adult brain in comparison to the developing brain, we hypothesised 
that other mechanisms would underlie OP-induced neurological effects in adults.   
The aim of this study was to investigate the effects of chronic low level OP exposure in adults.  Brain regions 
associated with psychiatric and neurobehavioural outcomes were selected: the dorsal raphe nucleus (DRN), the major source 
of 5-HT monoaminergic neurones in the brain and heavily implicated in the aetiology of anxiety and depression, and the 
hippocampus, which plays a key role in learning and memory. Adult male rats were orally exposed to the OP diazinon for 12 
weeks (5 days a week).   Diazinon is used in sheep dip and in some pet flea treatments but also has one of the highest dietary 
exposure risk factors for pesticides, mainly through fruit and vegetable ingestion (Melnyk et al., 2016).  Given that many brain 
proteins could underlie psychological disorder symptoms and neurobehavioural deficits, we measured changes in gene 
expression using microarray to make a comprehensive assessment. In addition, we assessed AChE and butrylcholinesterase 
(BChE) activity in blood and brain to determine if OP exposure was below the threshold to inhibit ChE activity, and also 
marble-burying behaviour during the chronic exposure period.  Marble burying behaviour is an ethological measure of anxiety 
in rodents, and we have found that it is a sensitive behavioural measure of low level OP exposure (Savy et al., 2015).    
 
2. Materials and methods 
 
2.1. Animals 
All animal procedures were carried out in adherence to the UK Home Office guidelines laid out in the Animals 
(Scientific Procedures) Act 1986 and the European Union Directive 2010/63/EU. Adult male Lister Hooded rats (Charles 
River, UK) (250-340g on arrival) were housed in groups of 4 in RC1 cages (56 x 38 x 20 cm) in a temperature controlled room 
(21–24°C) with 12:12h light/dark cycle (lights on at 07:00) with ad libitum access to food (RM03 rat chow, Charles River, 
UK) and water. After being delivered animals acclimatised for a minimum of 5 days before studies began.   Animals and their 
body weights were monitored throughout the study in order to calculate dosing volumes and monitor health.  
 
2.2. Treatments 
Diazinon (Greyhound Chromatography and Allied Chemicals, UK) was suspended in olive oil (1ml/kg) shortly 
before administration and administered orally.  To avoid the stress of oral gavage, animals were trained to voluntarily ingest 
olive oil by licking the end of a syringe.  Voluntary ingestion training was conducted for several days prior to treatment.  For 
the study we wanted to administer very low diazinon levels so we conducted a pilot dose-ranging study (0, 1, 2, 4 mg / kg for 
5 days; n = 6 per dose) to determine if repeated oral diazinon doses inhibited ChE activity. AChE activity was not affected but 
4 mg / kg diazinon significantly inhibited BChE  (Bonferonni post hoc comparisons, p < 0.05; Supplementary Figure 1), so 
for the main study animals received diazinon doses of 0, 1 or 2 mg / kg (n = 12 per dose) for 12 weeks, 5 consecutive days per 
week. 
  
2.3. Behaviour  
Marble burying-behaviour was assessed before treatment began and then every 4 weeks during treatment.  Tests 
were conducted 72 hours after a 5 day treatment period, between 09:00 and 11:00 under 40W white light. Briefly, rats were 
placed in individual test cages containing a 5 cm layer of sawdust and 9 glass marbles arranged evenly at one end of the cage 
for 10 mins. The number of marbles buried, the latency to first dig, latency to bury the first marble, time spent in the marble 
half of the cage and frequency of rears were recorded (Savy et al., 2015).  
 
2.4. Tissue collection 
 Six weeks after exposure, tail vein blood was collected in heparinised tubes, diluted 1:25 with 0.1% saponin solution 
and stored in aliquots at -20°C until analysis for ChE activity.  Seventy-four hours after the final diazinion dose animals were 
overdosed with isoflurane.  Trunk blood was collected in heparinised tubes, diluted 1:25 with 0.1% saponin solution and stored 
in aliquots at -20°C.  Brains were rapidly removed and cut into 3 mm coronal slices using a brain block. Slices were placed on 
microscope slides, rapidly frozen on dry ice and stored at -80°C until dissection.  
 
2.5. Cholinesterase activity 
The prefrontal cortex, caudate putamen, hippocampus, substantia nigra and cerebellum from the left hemisphere (n 
= 12 per dose) and whole dorsal raphe nucleus (n = 6 per dose) were dissected on ice, homogenised in ice-cold Tris buffered 
 saline (pH 7.4) and diluted 1:25 in 0.1% saponin solution and frozen at -20°C.    Protein concentration in brain homogenate 
was quantified using a bicinchoninic acid assay (Sigma Aldrich); samples (and bovine serum albumin standards) were 
incubated 1:20 with the bicinchoninic acid reagents at 37°C for 30 minutes before absorbance was read at 562 nm. AChE and 
BChE in tissue samples were quantified using a modified version of Ellmans colorimetric assay (de Blaquiere et al., 2000; 
Ellman et al., 1961). Briefly, brain homogenate or blood (diluted a further 1:5 with 0.1% saponin) (10 µl) was added to wells 
with phosphate buffered saline (110 µl, 0.1M, pH 7.4), the chromatogen 5,5’-dithio-bis-2nitro-benzoate (DTNB; 99 µl, 0.25 
mM, Sigma-Aldrich Company Ltd) and either acetyl-β-(methyl)thiocholine iodide (11 µl, 155 mM; Greyhound 
Chromatography, UK) or butyrylthiocholine iodide (11 µl, 218 mM; Greyhound Chromatography, UK) as the substrate.  
Absorbance of DTNB was read at 412 nm for 30 minutes (blood 35°C; brain homogenate 25°C).  AChE and BChE activity 
was expressed as nmol min-1 ml-1 for blood and nmol min-1 µg-1 protein for brain homogenate. 
 
2.6. Brain gene expression 
The hippocampus from the right hemisphere (0, 2 mg / kg diazinon, n = 12 per dose) and whole dorsal raphe nucleus 
(0, 2 mg / kg diazinon, n = 6 per dose) were dissected on dry ice, homogenised in Tri Reagent (Sigma-Aldrich) and stored at 
-80ºC until further preparation. RNA was extracted from homogenate using the RNeasy kit for RNA extraction (Qiagen, 
Valencia, CA, USA). Homogenate samples were incubated for 5 mins at room temperature with bromochloropropane (100µl) 
and then centrifuged (12,000 x g, 10 mins, 4ºC). The aqueous phase (400µl) was vortexed with 100% ethanol (200µl), 
transferred to a filter cartridge-collection tube assembly and centrifuged (12,000 x g, 30 secs, room temperature). The flow-
through was discarded and the filter cartridge-collection tube assembly washed and centrifuged twice.  The samples in the 
filter cartridges were incubated at room temperature for 2 mins with elution buffer (100µl) and centrifuged (30 secs, room 
temperature) to elute the RNA from the filter. Samples were stored at -20ºC and shipped on dry ice to AROS Applied 
Biotechnology (Denmark), who used Affymetrix GeneChip® HT RG-230 PM 24-Array Plate on the Gene Titan platform to 
conduct expression profiling according to the manufacturer’s instructions. The HT RG-230 PM Array Plate (Affymetrix) 
enables the measurement of gene expression of more than 30,000 transcripts and variants from more than 28,000 rat genes on 
a single array.  
 
2.7. Statistical analysis 
Data were analysed using SPSS.  Body weight comparisons were made using a repeated measures ANOVA (time 
as within subject factor; treatment as the between subject factor). ChE activity comparisons were made using one way 
ANOVAs (6 week blood ChE activity, vehicle brain ChE activity) or repeated measures ANOVAs (blood/brain region as the 
within subject factor; treatment as the between subject factor), followed by Bonferonni post hoc comparisons. Marble burying 
behavioural comparisons were made using a repeated measures ANOVA (time as within subject factor; treatment as the 
between subject factor) followed by one way ANOVAs for each 4 week period or treatment group, and Bonferonni post hoc 
comparisons.   Data are represented as the mean ± SEM.  
Statistical analysis for the gene expression data was conducted by the Bioinformatics Service (Newcastle 
University). Briefly, after hybridisation of expression chips, raw data were exported to the Bioconductor package, RankProd 
(Hong et al., 2006), log-scale transformed (log, basis 2) and normalised (non-linear transformation employing the loess 
smoother). Probe sets (78,963) were detected in all samples (20% and 90% bound of the fluorescence intensity of the chip). 
For the detection of gene expression changes, an ANOVA was applied with a cut off at a false discovery rate p < 0.05 
(Benjamini and Hochberg, 1995). Ingenuity pathway analysis was conducted on genes that were significantly altered to 
generate functions and canonical pathways using the Ingenuity Systems reference set (Ingenuity Knowledge Base) that were 
most significant to the data set. The p value was determined by the probability that the association between the genes in the 
dataset and the function or canonical pathway is explained by chance alone. The significance of the association between the 
data set and the function or canonical pathway was calculated using Fischer’s exact test. Finally network analysis was used to 
identify networks of altered genes. Networks were generated using the IPA Network Generation Algorithm and scored based 
on the number of network eligible molecules they contained from the dataset (Elstner et al., 2011). 
 
3. Results 
 
3.1. Body weight is unaffected by chronic low level exposure to diazinon  
Body weights increased during treatment but there was no effect of diazinon exposure on weight (main effect of 
time; F (1.4,46) = 1086.3, p < 0.001, effect of treatment; F (2,32) = 0.4, p = 0.666). 
 
3.2. Cholinesterase activity is unaffected by chronic low level exposure to diazinon 
Six weeks into the chronic diazinon exposure period tail blood samples were taken.  AChE activity and BChE activity 
in the blood samples were not affected by oral exposure to diazinon (0, 1, 2 mg / kg, n = 12 per dose; AChE F(2,33) = 1.3, p = 
0.280; BChE F(2,33) = 2.0, p = 0.146; Supplementary Figure 2).   After 12 weeks of diazinon exposure trunk blood and brain 
samples were collected.   AChE activity and BChE activity in samples collected from animals administered vehicle (0 mg / kg 
diazinon) varied between different brain regions (Table 1). Blood and brain AChE or BChE activity in samples collected from 
diazinon-exposed animals were not significantly different to activity in the vehicle group (Table 1).  
 
3.3. Anxiety-like behaviour in the marble burying test is affected by low level exposure to diazinon 
Marble burying behaviour was assessed before treatment began (0 weeks) and after 4, 8 and 12 weeks of diazinon 
exposure (0, 1, 2 mg / kg; n = 11-12 per dose).  Before treatment began, there was no difference between treatment groups but 
after 4, 8 and 12 weeks of exposure the number of marbles buried by diazinon-exposed groups was significantly lower in 
comparison to the vehicle group (Figure 1a, Table 2). The number of marbles buried by animals administered vehicle (0 mg 
/kg diazinon) did not change significantly over the 12 week test period (Figure 1a, Table 2). The latency to bury the first marble 
 in diazinon-exposed groups was also significantly higher in comparison to the vehicle group, (Figure 1b), although further 
analysis revealed this was only significant after 12 weeks of exposure (Table 2). The latency to first dig (Figure 1c), the 
frequency of rears (Figure 1d), and the time spent in the marble half of the cage (Figure 1d) increased over the course of the 
12 week test period but were not affected by diazinon exposure (Table 2).    
    
Table 1. Acetylcholinesterase (AChE) and butrylcholinesterase (BChE) activity following chronic oral exposure to the pesticide diazinon in 
the adult rat. ChE activity in samples collected from rats treated with 0 mg / kg diazinon (olive oil) varied significantly between brain regions 
(One way ANOVA; AChE F(5,65) = 596.8, p < 0.001; BChE F(5,65) = 89.9, p < 0.001). Diazinon exposure (0, 1, 2 mg / kg) for twelve weeks 
had no significant effect on blood and brain AChE or BChE activity (repeated measures ANOVA; AChE main effect of treatment F(2,14) = 0.2, 
p = 0.98, main effect of region F (6,84) = 3.06, p < 0.01, treatment*region interaction F (12,84) = 0.45, p = 0.68; main effect of treatment BChE 
F(2,14) = 0.7, p = 0.94, main effect of region F (6,84) = 1.75, p = 0.12, treatment*region interaction F (12,84) = 1.17, p = 0.32).   
 
  Acetylcholinesterase activity  
  nmol/ min % of 0 mg /kg activity 
Diazinon dose  0 mg /kg 0 mg /kg 1 mg / kg 2 mg /kg 
    Mean ± SEM n Mean ± SEM n Mean ± SEM n 
Prefrontal cortex 98.0 ± 1.4 100.0 ± 1.3 12 97.8 ± 1.7 11 98.7 ± 2.1 12 
Caudate putamen 689.0 ± 20.0 100.0 ± 2.8 12 91.8 ± 2.6 10 96.7 ± 3.1 11 
Hippocampus 108.2 ± 5.6 100.0 ± 5.0 12 87.4 ± 3.4 11 99.2 ± 4.8 12 
Substantia nigra 160.9 ± 5.2 100.0 ± 3.1 12 117.7 ± 4.1 11 112.6 ± 4.0 12 
Dorsal raphe nucleus 244.2 ± 12.7  100.0 ± 4.8 6 101.8 ± 16.3 5 111.6 ± 8.0 6 
Cerebellum 61.0 ± 2.9  100.0 ± 4.6 12 93.5 ± 3.5 11 92.2 ± 1.6 12 
Blood  4.1 ± 0.3 100.0 ± 4.5 12 103.8 ± 4.9 11 94.6 ± 2.8 12 
        
  Butrylcholinesterase activity 
  nmol/ min   % of 0 mg /kg activity 
Diazinon dose  0 mg /kg 0 mg /kg 1 mg / kg 2 mg /kg 
    Mean ± SEM n Mean ± SEM n Mean ± SEM n 
Prefrontal cortex 15.7 ± 0.7 100.0 ± 4.2 12 96.8 ± 1.7 11 94.4 ± 2.5 12 
Caudate putamen  20.0 ± 0.6 100.0 ± 2.9 12 94.9 ± 5.5 11 90.3 ± 2.5 11 
Hippocampus 16.5 ± 0.4 100.0 ± 2.3 12 92.6 ± 3.2 11 92.8 ± 2.4 12 
Substantia nigra 30.6 ± 1.1  100.0 ± 3.5 12 111.2 ± 6.1 11 101.2 ± 4.4 12 
Dorsal raphe nucleus 37.7 ± 1.8 100.0 ± 4.3 6 97.3 ± 18.3   5 101.9 ± 5.8 6 
Cerebellum  22.6 ± 0.6 100.0 ± 2.5 12 101.5 ± 2.0 11 99.8 ± 2.1 12 
Blood  2.5 ± 0.2 100.0 ± 4.7 12 103.7 ± 3.5 11 100.8 ± 2.0 12 
  
 
3.4. Gene expression in the hippocampus is affected by chronic low level exposure to diazinon 
Of the 31,842 probe sets significantly detected in hippocampal samples (7796 up-regulated, 24046 down-regulated), 
the signal intensity of 430 were significantly different between samples from vehicle and diazinon treated animals (Table 3, 
full list available at Judge et al. (2017).  
Many of the hippocampal genes affected by diazinon exposure were involved in synaptic transmission; diazinon 
exposure up-regulated the gene encoding unc13 (unc13c; 1.89 fold change), which primes synaptic vesicles for release (Lee 
et al., 2013) and down-regulated the gene encoding synapsin II (syn2; 0.66 fold change), which clusters vesicles in the synaptic 
reserve pool (Vasileva et al., 2012).  Neurones lacking synapsin may release neurotransmitters faster as vesicles are not 
confined to the reserve pool.  Several genes associated with glutamatergic neurotransmission were up-regulated by diazinon 
exposure: glutaminase (gls; 1.92 fold change), a glutamate synthesis enzyme, mitogen-activated protein kinase 8 (mapk8; 2.12 
fold change), which regulates many cellular processes including apoptosis, proliferation and AMPA receptor trafficking (Adler 
et al., 2011), Glu3 (gria3; 1.71 fold change), one of the AMPA receptor subunits, neurexin 3 (nrxn3; 1.71 fold change), which 
stabilises AMPA receptors in the neuronal membrane (Aoto et al., 2015), and versican (vcan; 1.73 fold change), an 
extracellular matrix protein which may form a complex with hippocampal AMPA receptors (Saroja et al., 2014). Diazinon 
exposure also altered the expression of genes involved in dopaminergic transmission; genes encoding tyrosine hydroxylase, a 
dopamine synthesis enzyme (th; 1.09 fold change) and the dopamine transporter (slc6a3;1.59 fold change) were up-regulated 
whereas the gene encoding neurotensin (nts; 0.57 fold change), a neuropeptide involved in modulating the effects of other 
neurotransmitters on dopaminergic neurotransmission (Binder et al., 2001), was down-regulated.  Diazinon exposure also 
down-regulated the genes encoding the GABAB1 receptor (gabbr1; 0.64 fold change) and the 5-HT5B receptor (htr5b; 0.58 
fold change).  Apart from the down-regulation of the gene encoding choline O-acetyltransferase (chat; 0.68 fold change), an 
acetylcholine synthesis enzyme, diazinon exposure did not significantly affect any other genes specifically related to 
cholinergic transmission.  Some of the largest fold changes were in genes involved in neural cell development; the genes 
 encoding neurogenic differentiation factor 1 (neurod1; 2.89 fold change) and kit ligand also known as stem cell factor (kitgl; 
2.06 fold change) were up-regulated.    
Ingenuity pathway analysis generated functions and canonical pathways that were associated with the hippocampal 
genes most significantly affected by diazinion exposure. The most over represented biological     functions were Psychological 
Disorders, and Cell-To-Cell Signalling and Interaction (Table 4, full list available at Judge et al. (2017)). The most over 
represented canonical pathways were Nitrogen metabolism, D-glutamine and D-glutamate metabolism, Epidermal growth 
factor signalling, Huntington’s disease signalling, and Glutamate Receptor signalling (Table 5). 
 
       
        
 
Figure 1 Chronic oral exposure to the pesticide diazinon significantly altered marble burying behaviour in the rat. (a) The number of marbles 
buried was significantly lower and (b) the latency to bury the first marble was significantly higher in diazinon-exposed groups in comparison 
to the 0 mg/ kg group (vehicle). (c) The latency to first dig, (d) the frequency of rears and (e) the time spent in the marble half of the cage, 
were not affected by diazinon exposure but these measures did increase over the course of twelve week test period. Mean ± SEM. * p < 0.05 
in comparison to vehicle group 
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 Table 2  Statistical test results showing the effect of oral diazinon exposure (0, 1 , 2 mg /kg) or weeks of treatment (0, 4, 8, 12) on adult rat 
behaviour in the marble burying test. 
  
Repeated measures ANOVA One way ANOVA 
 Behaviours All data 0 weeks 4 weeks 8 weeks 12 weeks 
  F (df) P F (df) P F (df) P F (df) P F (df) P 
Dose Number of marbles 
buried 
7.2(2,32) 0.003 0.4(2,32) 0.66 9.0(2,32) 0.001 4.2(2,32) 0.025 6.6(2,32) 0.004 
 Latency to bury first 
marble 
9.5(2,32) 0.036 0.1(2,32) 0.94 2.3(2,32) 0.118 1.2(2,32) 0.301 4.4(2,32) 0.020 
 Latency to first dig 1.0(2,32) 0.362         
 Frequency of rears 1.5(2,32) 0.247         
 Time in marble half 
of cage 
0.4(2,32) 0.704         
    0 mg/kg 1 mg/kg 2 mg/kg  
    F (df) P F (df) P F (df) P   
Week Number of marbles 
buried 
18.2(3,96) 0.000 1.9(3,44) 0.15 6.3(3,42) 0.001 9.5(3,44) 0.000   
 Latency to bury first 
marble 
16.2(3,96) 0.000 2.2(3,44) 0.10 5.9(3,42) 0.002 8.5(3,44) 0.000   
 Latency to first dig 9.3(3,96) 0.000 1.8(3,44) 0.16 5.5(3,42) 0.003 2.2(3,44) 0.097   
 Frequency of rears 8.4(3,96) 0.000 0.2(3,44) 0.86 1.9(3,42) 0.147 0.4(3,44) 0.750   
 Time in marble half 
of cage 
28.8(3,96) 0.000 7.7(3,44) 0.000 9.3(3,42) 0.000 6.3(3,44) 0.001   
            
Dose x 
week 
Number of marbles 
buried 
3.2(6,96) 0.006         
 Latency to bury first 
marble 
1.5(6,96) 0.179         
 Latency to first dig 0.5(6,96) 0.844         
 Frequency of rears 0.3(6,96) 0.939         
 Time in marble half 
of cage 
0.4(6,96) 0.902         
 
 
In order to visualise connections between the hippocampal genes most significantly affected by diazinon exposure 
and identify other genes in the network, affected genes were mapped into Ingenuity pathway analysis networks (Judge et al., 
2017).   The two highest scoring networks (networks containing the most genes affected by diazinon exposure) were the Cell 
Death, Genetic Disorder and Cellular Assembly and Organisation network (Figure 2), and the Cell-To-Cell Signalling and 
Interaction, Nervous system development and function and Molecular transport network (Figure 3).  The Cell Death, Genetic 
Disorder and Cellular Assembly and Organisation network is enriched with genes encoding proteins involved with synaptic 
plasticity and proliferation:  Akt (akt), a serine/threonine-specific protein kinase involved in multiple cellular processes such 
as glucose metabolism, apoptosis, cell proliferation (Alessi et al., 1996), fragile X mental retardation protein (fmr1), a binding 
protein involved in synaptic plasticity, platelet derived growth factor (Pdgfbb), which is involved in cell proliferation and 
differentiation, stem cell factor (kitlg) and C-Jun N-terminal kinase 1 (mapk8) mentioned previously.  The Cell-To-Cell 
Signalling and Interaction, Nervous system development and function and Molecular transport network is enriched with genes 
encoding proteins associated with synaptic transmission: the N-type voltage dependent calcium channel subunit (Cacna1b), 
which is involved neurotransmitter release from the presynaptic terminals, the inhibitory receptors GABAB1 (gabbr1) and 
GABAB2 receptors (gabbr2), the excitatory 5-HT2C receptor (htr2c), the post-synaptic density protein 95 (Dlg4), which is 
necessary for NMDA receptor signalling (Stephenson, 2006) and calcium/calmodulin-dependent serine protein kinase (Cask), 
a scaffolding protein involved in synaptic transmembrane protein anchoring and ion channel trafficking (Hsueh, 2006).  In 
addition, the gene encoding huntingtin (htt), which is involved in many cellular processes including vesicle trafficking, 
postsynaptic signalling and apoptosis (Cattaneo et al., 2001; Gutekunst et al., 1995; Nasir et al., 1995) is central to this network.  
 
 
 
 
 
 
 
 
 
 
 
 
 Table 3 List of genes with most significant differences in expression between hippocampal samples from vehicle and diazinon treated animals. 
Fold changes above 1 are up-regulated, fold changes below 1 are down-regulated.  
 
Gene name Protein name Fold change  P Value 
Ogn Osteoglycin  2.35 0.001 
Coch Coagulation factor C homolog  2.18 0.001 
Mapk8 Mitogen-activated protein kinase 8  2.12 0.001 
Neurod1 Neurogenic differentiation factor 1 2.89 0.002 
Nars2 Asparaginyl-tRNA synthetase 2  2.23 0.002 
Usp33 Protein Usp33 2.16 0.002 
Ptprd Receptor-type tyrosine-protein phosphatase delta isoform 2.17 0.003 
Slc6a3 Sodium-dependent dopamine transporter (DA transporter) 1.59 0.003 
Tubb2c Tubulin beta-4B chain 2.19 0.003 
Etv1 Ets variant 1 2.17 0.003 
Atp2b1 Calcium-transporting ATPase 2.07 0.003 
Sfrs18 PNN-interacting serine/arginine-rich protein 2.05 0.003 
Col1a2 Collagen alpha2 type I 1.71 0.004 
Kitlg Kit ligand 2.06 0.004 
slc13a4 Solute carrier family 13, member 4 1.63 0.004 
Sema6a Semaphorin 6A 1.99 0.005 
UBE3A Ubiquitin protein ligase E3A 1.89 0.007 
Col1a2 Collagen alpha2 type I 1.58 0.007 
sltm Similar to modulator of estrogen induced transcription 1.94 0.008 
Ano3 Anoctamin 3 1.85 0.008 
rnpc3 RNA-binding region (RNP1, RRM) containing 3 1.91 0.008 
Klhl4 Kelch-like family member 4 1.93 0.008 
Gls Glutaminase 1.92 0.009 
Fat2 Protocadherin Fat 2 1.86 0.009 
Ca8 Carbonic anhydrase-related protein 1.86 0.010 
atrx ATRX, chromatin remodeler 1.89 0.010 
Lum Lumican  1.83 0.010 
hnrnpa2b1 Heterogeneous nuclear ribonucleoprotein A2/B1 1.85 0.011 
Unc13c Protein unc-13 homolog C (Munc13-3) 1.89 0.011 
Slc6a20 Sodium- and chloride-dependent transporter XTRP3 1.60 0.011 
Uba6 Protein Uba6 1.90 0.011 
Zcchc7 Zinc finger CCHC domain-containing protein 7  1.91 0.011 
Eif3a Eukaryotic translation initiation factor 3, subunit A 1.87 0.013 
Cp Ceruloplasmin 1.85 0.013 
Colec12 Collectin-12 1.82 0.013 
Sfrs18 PNN-interacting serine/arginine-rich protein 1.79 0.013 
Zeb2 Zinc finger E-box binding homeobox 2 1.88 0.013 
col8a2 Collagen, type VIII, alpha 2 1.56 0.014 
Mysm1 histone H2A deubiquitinase  1.84 0.014 
Sass6 Spindle assembly abnormal protein 6 homolog 1.84 0.014 
BMP6 bone morphogenetic protein 6 1.59 0.014 
    
Chat Choline O-acetyltransferase 0.68 0.002 
Crlf1 Cytokine receptor-like factor 1  0.58 0.003 
Lancl1 LanC-like protein 1 0.61 0.003 
Nts Neurotensin/neuromedin N 0.57 0.003 
Htr5b 5-hydroxytryptamine receptor 5B 0.58 0.005 
Crabp1 Cellular retinoic acid-binding protein 1  0.58 0.012 
Fzr1 Fizzy/cell division cycle 20 related 1  0.63 0.013 
Klhl22 Kelch-like protein 22 0.63 0.013 
Nisch Nischarin (Imidazoline receptor 1)  0.62 0.014 
Ttr Transthyretin 0.68 0.014 
Cryba2 BetaA2-crystallin 0.56 0.015 
 
 
 
 
 
 Table 4 Biological Functions most relevant to hippocampal genes significantly altered by chronic diazinon exposure in the adult rat identified 
using Ingenuity Pathway Analysis. 
Biological Functions P value Genes 
Psychological Disorders 9.07E-06-3.3E-02 PBRM1,SLC24A2,NRXN3,TUBB2C,DDX42,MITF,FMR1,GABBR1,SFPQ,C
P,HTR5B,ITPR1,FZR1,SLC6A3,KITLG,ZEB2,CALB1,BMP6,SYN2,PPARG
C1A,GRIA3 
Cell-To-Cell Signalling and 
Interaction 
1.24E-05-3.64E-02 NEUROD1,GCHFR,UNC13C,NRXN3,FMR1,GLS,NTS,GABBR1,Accn1,ITP
R1,MAPK8IP1,VCAN,SLC6A3,KITLG,CALB1,BMP6,SYN2,NISCH,LIN7C,
GRIA3 
Cell Death 3.33E-05-3.64E-02 NEUROD1,CRLF1,RBM5,ATP2B1,CDKN2D,ATRX,MAPK8,CCAR1,BOK,I
TPR1,UBE3A,MAPK8IP1,VCAN,SLC6A3,IQUB,KITLG,IMMT,TFRC,CAST
,CALB1,BMP6,SLC47A1,PPARGC1A 
Molecular Transport 6.6E-05-3.64E-02 MRC1,AP3S1,SLC24A2,UNC13C,NRXN3,ATP2B1,FMR1,HNRNPA2B1,NT
S,CP,Accn1,SLC6A3,HOOK3,HNRNPA3,SLC6A20,CALB1,HOOK1,NEURO
D1,SLC13A4,GABBR1,ITPR1,MAPK8IP1,KITLG,TFRC,CPNE7,SYN2,SLC4
7A1,PPARGC1A,GRIA3,LIN7C,NISCH 
Small Molecule Biochemistry 6.6E-05-3.64E-02 SLC24A2,UNC13C,GCHFR,NRXN3,MITF,GLS,MAPK8,NTS,GABBR1,CP,
MAPK8IP1,SLC6A3,KITLG,CLK1,IMMT,TFRC,EFEMP1,BMP6,CALB1,SY
N2,SLC47A1,PPARGC1A,NISCH,LIN7C 
Cellular Function and Maintenance 7.83E-05-3.13E-02 MRC1,NEUROD1,SLC24A2,UNC13C,FMR1,CDKN2D,SEMA6A,MAPK8,C
P,ITPR1,UBE3A,KITLG,HOOK3,MPP5,TFRC,CAST,BMP6,CALB1,HOOK1,
SYN2,PPARGC1A 
Nervous System Development and 
Function 
9.75E-05-3.64E-02 COL8A2,UNC13C,NRXN3,FMR1,NTS,Accn1,SPAG9,VCAN,IQUB,SLC6A3
,CAST,CALB1,NEUROD1,MITF,GLS,ATRX,CDKN2D,MAPK8,GABBR1,IT
PR1,MAPK8IP1,UBE3A,ZEB2,BMP6,SYN2,PPARGC1A,GRIA3 
Cell Morphology 2.04E-04-3.64E-02 NEUROD1,KITLG,FMR1,LUM,MAPK8,ITPR1,CAST,BMP6,IQUB,LIN7C,P
PARGC1A 
Cell Signalling 3.7E-04-2.44E-02 SLC24A2,ATP2B1,MAPK8,ITPR1,SPAG9,MAPK8IP1,MDFIC 
 
 
Table 5 Cell signalling and metabolic pathways most relevant to hippocampal genes in the adult rat significantly altered by chronic low level 
diazinon exposure, identified using Ingenuity Pathway Analysis.   
 
Ingenuity Canonical Pathways P value Genes Protein 
Nitrogen Metabolism 0.020 GLS glutaminase 
   CA8 carbonic anhydrase VIII 
D-glutamine and D-glutamate Metabolism 0.025 GLS glutaminase 
Epidermal growth factor  signalling 0.032 MAPK8 mitogen-activated protein kinase 8 
interacting 
  ITPR inositol 1,4,5-trisphosphate receptor, type 1 
Huntington's Disease Signalling 0.046 NEUROD1 neurogenic differentiation 1 
  GLS glutaminase 
  MAPK8 mitogen-activated protein kinase 8 
interacting 
  ITPR1 inositol 1,4,5-trisphosphate receptor, type 1 
Glutamate Receptor signalling 0.048 GLS glutaminase 
   GRIA3 AMPA3 receptor subunit 
 
 
  
  
Figure 2 Primary network of differentially expressed genes identified in the adult rat hippocampus after chronic low level exposure to diazinon 
using Ingenuity pathway analysis. The main functions of this network are Cell death, Genetic disorders and Cellular assembly and organisation. 
Up-regulated and down-regulated genes are highlighted in green and red respectively. 
 
 
  
Figure 3 Secondary network of differentially expressed genes identified in the adult rat hippocampus after chronic low level exposure to 
diazinon using Ingenuity pathway analysis. The main functions of this network are Cell-To-Cell signalling, Nervous system development and 
function, and Molecular transport. Up-regulated and down-regulated genes are highlighted in green and red respectively.  
 
 
3.5. Gene expression in the dorsal raphe nucleus is affected by chronic low level exposure to diazinon 
Of the 47,121 probe sets significantly detected in dorsal raphe samples (23,558 up-regulated, 23,563 down-
regulated), the signal intensity of 70 was significantly different between samples from vehicle and diazinon treated animals 
(Table 6, full list available at Judge et al. (2017)). 
Diazinon exposure up-regulated several dorsal raphe nucleus genes encoding proteins associated with synaptic 
transmission: the α1b-adrenoceptor (adra 1b; 1.50 fold change), the main driver of 5-HT neuronal excitation (Baraban and 
Aghajanian, 1980), the regulator of G protein signalling 4 (rgs4; 1.88 fold change), which dampens the effects of G-protein 
coupled receptors including the inhibitory 5-HT1A autoreceptor in the dorsal raphe nucleus (Beyer et al., 2004),  gastrin-
releasing peptide (Grp; 1.89 fold change), which depolarises 5-HT neurones (Pinnock and Woodruff, 1991) and complexin 3 
(cplx3; 1.77 fold change), which facilitates neurotransmitter release (Yang et al., 2013). In contrast, genes encoding proteins 
associated with xenobiotic uptake and metabolism were down-regulated: the cytochrome P450, family 1, subfamily B, 
polypeptide (cyp1b1; 0.52 fold change), which metabolises xenobiotics and the solute carrier organic anion transporter family 
1A2 (Slco1a5; 0.71 fold change), involved in cellular uptake.   
Ingenuity pathway analysis revealed that the genes in the dorsal raphe nucleus significantly affected by diazinon 
exposure were most strongly associated with development.  The most over represented functions were Embryonic 
Development and Nervous System Development and Function (Table 7, full list available at Judge et al. (2017)).  The 
 
 Psychological Disorders function was also over represented.  Canonical pathways were identified but none were over 
represented.  The highest scoring network (network containing the most genes affected by diazinon exposure) was the 
Endocrine system development, Lipid metabolism and Small molecule biochemistry network (Figure 4; full list available at 
Judge et al. (2017)).  Central to this network are genes encoding proteins associated with synaptic structure and synaptic 
signalling: extracellular regulated kinase 1/2 (erk1/2), involved in many processes including proliferation and synaptic 
plasticity, and huntingtin (htt), the α1b-adrenoceptor (adra1b) and regulator of G protein signalling 4 (rgs4), mentioned 
previously. In addition the network is enriched with genes encoding endocrine system proteins: transthyretin (ttr), which 
transports thyroid hormone, prolactin receptor (prlr) and follicle-stimulating hormone (fsh).   
 
 
Table 6 List of dorsal raphe nucleus genes with most significant differences in expression between rats treated with vehicle and diazinon. 
Fold changes above 1 are up-regulated, fold changes below 1 are down-regulated.  
Gene name Protein name Fold change  P Value 
Hs3st2 Heparan sulfate glucosamine 3-O-sulfotransferase 2 2.08 0.000 
IPCEF1 Interaction protein for cytohesin exchange factors 1 2.38 0.000 
Nxph3 Neurexophilin-3 1.88 0.000 
Rprm Reprimo, TP53 dependent G2 arrest mediator candidate 2.16 0.000 
Ldb2 LIM domain binding 2 1.93 0.002 
Cbln2 Cerebellin-2 1.87 0.003 
Grp Gastrin-releasing peptide 1.89 0.003 
Bmper BMP-binding endothelial regulator 1.84 0.003 
Rgs4 Regulator of G-protein signaling 4  1.88 0.003 
Gfra2 Glial cell line derived neurotrophic factor family receptor alpha 2 1.86 0.003 
Sstr1 Somatostatin receptor 1.84 0.003 
Cplx3 Complexin III 1.77 0.005 
Foxp2 Forkhead box protein P2 2.01 0.010 
Igfbp6 Insulin-like growth factor-binding protein 6 1.68 0.010 
Homer1 Homer protein homolog 1 1.63 0.011 
P4ha3 Prolyl 4-hydroxylase subunit alpha 3 1.69 0.012 
Rgs    4 Regulator of G-protein signaling 4 1.71 0.016 
GARNL3 GTPase activating Rap/RanGAP domain-like 3 1.63 0.021 
Pbld Phenazine biosynthesis-like domain-containing protein 1.51 0.025 
Myh2 /// Myh3 Myosin heavy chain 1.39 0.034 
Inpp5d Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1 1.54 0.038 
adra1b α-1B adrenergic receptor 1.50 0.042 
    
Mfrp Membrane frizzled-related protein  0.48 0.000 
Sostdc1 Sclerostin domain-containing protein 1 0.52 0.000 
Cyp1b1 Cytochrome P450 1B1  0.52 0.002 
F5 Coagulation factor V  0.68 0.002 
Tmem27 Transmembrane protein 27 0.52 0.004 
Otx2 Homeobox protein OTX2 0.56 0.004 
Prlr Prolactin receptor, isoform CRA_a 0.53 0.008 
col8a2 Collagen, type VIII, alpha 2 0.65 0.013 
Slco1a5 Sodium-independent organic anion transporter 1 0.71 0.014 
Folr1 Folate receptor 1  0.70 0.014 
Kcne2 Potassium voltage-gated channel subfamily E member 2  0.68 0.026 
Rbm47 RNA-binding protein 47 0.66 0.027 
Ttr Transthyretin 0.50 0.027 
Krt18 Keratin, type I cytoskeletal 18 0.68 0.037 
Col8a1 Collagen, type VIII, alpha 1 0.60 0.038 
slc13a4 Solute carrier family 13 member 4 0.72 0.040 
Scgb1c1 Secretoglobin family 1C member 1  0.75 0.050 
 
4. Discussion 
Chronic oral exposure to the pesticide diazinon during adulthood, below the threshold to significantly affect AChE 
or BChE activity, significantly altered anxiety-like behaviour.  Furthermore, chronic exposure to diazinon altered the 
expression of genes associated with synaptic transmission and plasticity, and neuronal development in brain regions associated 
with psychological disorders and neurobehavioural deficits. 
 
4.1. Length and level of exposure 
In this study adult animals were exposed to diazinon for 12 weeks. Whilst we accept this does not mimic exposure 
to diazinon through the use of sheep dip a few times a year, it does relate to workers that regularly use diazinon (for example 
 sheep dipping contractors), people consuming fruit and vegetables contaminated with diazinion (Melnyk et al., 2016), and 
people living with pets coated with diazinon; flea collars containing as much as 3.6 g of diazinon slowly release the product 
to spread over the pet’s coat. Animals were orally exposed to 1 - 2 mg / kg diazinon which we consider to be low level 
exposure. Diazinon exposure did not significantly affect AChE and BChE activity and though choline O-acetyltransferase 
gene expression (chat) was down-regulated, indicating a decrease in hippocampal acetylcholine, no other cholinergic genes 
were affected.  Taken together this would suggest that diazinon exposure was insufficient to inhibit AChE activity and that the 
down-regulation of chat was due to another mechanism (see Gene expression changes subsection).    
 
Table 7 Biological Functions most relevant to dorsal raphe nucleus genes significantly altered by chronic diazinon exposure in the adult rat 
identified using Ingenuity Pathway Analysis. 
 
Biological Functions P value Genes 
Embryonic Development 1.11E-05-4.95E-02 COL8A2,FOXP2,SOSTDC1,RGS4,COL8A1,BMPER,GFRA2,PRL
R,CYP1B1,ADRA1B,OTX2,LDB2 
Nervous System Development and 
Function 
1.11E-05-4.95E-02 CPLX3,IGFBP6,FOXP2,COL8A2,TTR,COL8A1,RGS4,GFRA2,G
RP,HOMER1,CYP1B1,OTX2 
Organ Development 1.11E-05-4.95E-02 COL8A2,FOXP2,SOSTDC1,COL8A1,GFRA2,PRLR,HOMER1,O
TX2,CYP1B1,ADRA1B,LDB2 
Organismal Development 1.11E-05-4.95E-02 COL8A2,FOXP2,SOSTDC1,RGS4,COL8A1,BMPER,GFRA2,PRL
R,OTX2,CYP1B1,ADRA1B,LDB2 
Tissue Development 1.11E-05-4.95E-02 COL8A2,FOXP2,COL8A1,RGS4,GRP,GFRA2,PRLR,CYP1B1,A
DRA1B,INPP5D,OTX2,LDB2 
Visual System Development and 
Function 
1.11E-05-3.49E-02 COL8A2,FOXP2,MFRP,COL8A1,CYP1B1,OTX2 
Developmental Disorder 1.42E-05-4.18E-02 COL8A2,FOXP2,MFRP,TTR,RGS4,SSTR1,GRP,GFRA2,CYP1B1
,OTX2,INPP5D,HOMER1,ADRA1B 
Psychological Disorders 2.16E-05-4.99E-02 SHOC2,FOXP2,TTR,GARNL3,IPCEF1,SSTR1,COL8A1,RGS4,P4
HA3,HOMER1,ADRA1B,LDB2 
Cancer 3.73E-05-4.95E-02 IGFBP6,TTR,SSTR1,RGS4,GRP,CYP1B1,INPP5D,LDB2,SOSTD
C1,HS3ST2,PRLR,TMEM27,ADRA1B 
 
4.2. Behaviour 
 We have previously reported that marble burying behaviour is a sensitive behavioural measure of low level OP 
exposure (Savy et al., 2015), and the current study supports this.  Marble burying behaviour is frequently described as an 
ethological measure of anxiety in rodents and has been used to screen anxiolytic drugs in rodents (Broekkamp et al., 1986; 
Njung'e and Handley, 1991).  However, it has been suggested that the marble burying test is instead a measure of repetitive 
behaviour (digging) and the marbles are buried as a by-product of digging (Thomas et al., 2009).  If the marble burying test 
quantified anxiety-like behaviour, repeated testing would induce habituation and reduce anxiety-like behaviour.   In vehicle-
treated rats in this study none of the measures associated with digging (e.g. number of marbles buried, latency to first dig etc) 
were affected by repeated testing, indicating that these measures are probably not a measure of anxiety. Nevertheless, the 
number of marbles buried and the latency to first dig were sensitive to chronic diazinon exposure and indicates that exposure 
reduced repetitive behaviour.  
The biological changes underlying the diazinon-induced reductions in marble-burying are still unclear Lesioning 
studies have demonstrated the involvement of the hippocampus, nucleus accumbens and dorsal raphe nucleus in defensive 
burying behaviour (De Boer and Koolhaas, 2003) and reduced marble burying behaviour is correlated with increased 5-HT 
neurotransmission (Kobayashi et al., 2008; Njung'e and Handley, 1991).   We have previously shown that acute diazinon 
exposure can increase 5-HT neuronal firing in the dorsal raphe nucleus (Judge et al., 2016), which would lead to an increase 
in 5-HT release in forebrain areas.  In this study the up-regulation of the genes encoding  the α1b-adrenoceptor, the main driver 
of 5-HT neuronal excitation (Baraban and Aghajanian, 1980) and the regulator of G protein signalling 4, which dampens the 
effects of G-protein coupled receptors including the inhibitory 5-HT1A autoreceptor in the dorsal raphe nucleus (Beyer et al., 
2004), would suggest that chronic low level diazinon exposure also stimulates 5-HT neuronal firing.  Taken together we 
conclude that chronic diazinon exposure reduces marble-burying behaviour through an increase in 5-HT neurotransmission. 
 
4.3. Gene expression changes 
We used microarrays to make a comprehensive assessment of the effects of chronic diazinon exposure on the 
hippocampus and dorsal raphe nucleus. This approach allowed us to detect 31,842 probe sets in hippocampal samples and 
47,121 probe sets in dorsal raphe nucleus samples.  Detecting thousands of genes will lead to false positives which we 
controlled for statistically. 
Genes associated with the Psychological Disorders function were significantly affected by diazinon exposure in both 
the hippocampus and dorsal raphe nucleus.  Whilst this adds weight to the studies reporting low level OP exposure is associated 
with anxiety and depression (Bazylewicz-Walczak et al., 1999; Mackenzie Ross et al., 2010; Salvi et al., 2003; Steenland et 
al., 2000; Stephens et al., 1995), the following need to be considered.  The significant gene expression changes identified in 
this study were not confirmed using real-time polymerase chain reaction (RT-PCR), and the corresponding protein products 
were not quantified and so we cannot state with certainty that the individual changes detected resulted in changes in protein 
levels.  Nevertheless, gene expression changes are frequently indicative of protein level changes, multiple genes affected by 
diazinon exposure were associated with a particular function or network or pathway, and some of the significant gene 
expression changes are consistent with previously published studies (see below), all of which increases the likelihood the gene 
expression changes are relevant. 
  
  
Figure 4 Primary network of differentially expressed genes identified in the adult rat dorsal raphe nucleus after chronic low level exposure to 
diazinon using Ingenuity Pathway Analysis. The main functions of this network are Endocrine system development, Lipid metabolism and 
Small molecule biochemistry. Up-regulated and down-regulated genes are highlighted in green and red respectively.  
 
Many of the genes affected by diazinon exposure in both the hippocampus and dorsal raphe nucleus were associated 
with synaptic transmission and, in particular, monoaminergic neurotransmission.  As mentioned above gene expression 
changes indicate chronic diazinon exposure stimulates 5-HT neurotransmission (see Behaviour subsection).  Likewise, 
diazinon exposure up-regulated genes associated with dopaminergic neurotransmission.  These data are consistent with the 
gene expression changes induced by neonatal diazinon exposure (Slotkin and Seidler, 2007a), and, although th (tyrosine 
hydroxylase) was the only monoaminergic gene common to both studies, the gene expression changes overall indicate the 
same stimulatory effect on monoaminergic neurotransmission. In addition, chronic diazinon exposure in adults appears to 
stimulate glutamatergic neurotransmission, demonstrated by the up-regulation of genes encoding glutaminase, mitogen-
activated protein kinase 8, Glu3, one of the AMPA receptor subunits, neurexin 3, which stabilises AMPA receptors in the 
neuronal membrane (Aoto et al., 2015) and Homer protein homolog 1 which has been implicated in the regulation of 
metabotropic glutamate receptors (mGluR1a and mGluR5) (Bottai et al., 2002; Reim et al., 2001).  Exposure of PC12 cells, a 
developmental model, and neonatal rats to diazinon altered the expression of glutamate transporter and receptor genes (Slotkin 
and Seidler, 2007a; Slotkin and Seidler, 2009). Again, although dissimilar genes are affected, it appears that diazinon 
stimulates glutamatergic neurotransmission in neonates and adults.  
 
 What we had not predicted was that the most significantly affected genes, particularly in the dorsal raphe nucleus, 
would be associated with development.  The increased expression of genes strongly associated with proliferation, such as 
neurod1 and kitlg, and the Cell Death, Genetic Disorder and Cellular Assembly and Organisation network being the highest 
scoring network in the hippocampus, may indicate chronic diazinon exposure causes neuronal death followed by neurogenesis.    
Alternatively, the increased expression of genes associated with cellular assembly and organisation may indicate that chronic 
diazinon exposure causes neuronal restructuring.  Reorganisation and strengthening synapses to support increased 
neurotransmission is consistent with the other gene expression changes reported here. Previous reports on neonatal exposure 
indicate that diazinon exposure alters the expression of genes involved in neural cell development (Mankame, Hokanson et al. 
2006; Slotkin and Seidler 2007; Slotkin and Seidler 2010; Slotkin and Seidler 2012).  Given the overall similarities between 
the gene expression changes reported in neonates and here in adults, we postulate that the mechanism of action underlying 
diazinon-induced neurological effects during development may be similar to the mechanism of action in adulthood. 
To date this is the first study to report on genome wide changes following low level diazinon exposure in adulthood.  
Adulthood exposure for 21 days to another organophosphate pesticide, chlorpyrifos, has previously been reported to alter 
hippocampal gene expression but only at levels which induce ~ 90% cholinesterase inhibition, lower doses which induce ~50% 
ChE inhibition did not significantly alter gene expression, using microarray analysis (Lee et al., 2016).  Furthermore, the vast 
majority of genes altered by diazinon (n = 70) and chlorpyrifos (n = 50) were different, with chlorpyrifos significantly affecting 
genes encoding neurotrophins and neuropeptides such as brain-derived neurotrophic factor (Lee et al., 2016).  As neurotrophins 
and neuropeptides are involved in neural development and psychological disorders it could be argued that that there may be a 
shared mechanism of action, but given the differences in gene expression and that low level exposure to diazinon and 
chlorpyrifos can have disparate neurochemical effects (Savy et al., 2015), diazinon may have neurological effects below the 
threshold for cholinesterase inhibition that chlorpyrifos does not.  
 
4.4. Conclusion 
Chronic diazinon exposure levels below the threshold to inhibit cholinesterase, can alter gene expression.  Some of 
the genes most significantly affected are associated with the Psychological Disorders gene set, and glutamatergic and 
monoaminergic neurotransmission, which plays a key role in neurobehaviour and psychological disorders. Genes associated 
with development were also significantly affected by diazinon exposure in adulthood.  Whilst the results should be considered 
in view that corresponding protein products were not quantified, the gene expression changes are sufficient to cause 
behavioural changes.   Taken together the data are consistent with chronic low level diazinon exposure causing adverse 
neurological effects.     
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 SUPPLEMENTARY DATA 
 
 
 
 
Supplementary Figure 1. Acetylcholinesterase (AChE) and butrylcholinesterase (BChE) activity following 5 day repeated oral exposure to 
the pesticide diazinon in the adult rat. A. AChE activity was not affected by diazinon exposure (0, 1, 2, 4 mg /kg, n = 6 per dose; main effect 
of treatment F (3,17) = 0.90, p = 0.46, main effect of region F (6,102) = 0.51, p = 0.80, treatment*region interaction F (18,102) = 0.45, p = 0.97). B. 
BChE activity was affected by diazinon exposure (main effect of treatment F (3,18) = 3.94, p < 0.05, main effect of region F (6,108) = 0.55, p = 
0.77, treatment*region interaction F (18,108) = 0.45, p = 0.97) but only 4 mg / kg diazinon was significantly different to 0 mg / kg (Bonferonni 
post hoc comparisons, p < 0.05). Mean ± SEM. Prefrontal cortex (PFC), caudate putamen (CP),  hippocampus (HP), substantia nigra (SN), 
cerebellum (CB), dorsal raphe nucleus (DRN).  
 
 
  
 
Supplementary Figure 2. Blood acetylcholinesterase (AChE) and butrylcholinesterase (BChE) activity is not inhibited by six weeks oral 
exposure to the pesticide diazinon. Diazinon (0, 1, 2 mg /kg, n = 12 per dose) had no effect on blood AChE (F (2,33) = 1.3, p = 0.28; 0 mg / kg 
= 3.9 ± 0.1 nmol / min µl blood) or BChE activity  (F (2,33) = 2.0, p = 0.15; 0 mg / kg = 3.2 ± 0.1 nmol / min µl blood). Mean ± SEM.  
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